Get the Stockscreener App
0.7355
2.91%
0.0208
After Hours:
.74
0.0045
+0.61%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Canopy Growth Corp stock is traded at $0.7355, with a volume of 2.54M.
It is up +2.91% in the last 24 hours and down -20.06% over the past month.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
See More
Previous Close:
$0.7147
Open:
$0.7
24h Volume:
2.54M
Relative Volume:
0.87
Market Cap:
$311.14M
Revenue:
$199.30M
Net Income/Loss:
$-230.47M
P/E Ratio:
-0.5706
EPS:
-1.2891
Net Cash Flow:
$-58.89M
1W Performance:
-13.14%
1M Performance:
-20.06%
6M Performance:
-36.04%
1Y Performance:
-49.62%
1-Day Range:
$0.6915
$0.7408
1-Week Range:
$0.6915
$0.8599
52-Week Range:
$0.6915
$2.38
Canopy Growth Corp Stock (CGC) Company Profile
Name
Canopy Growth Corp
Sector
Phone
855-558-9333
Address
1 HERSHEY DRIVE, SMITH FALLS
Compare CGC vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corp
|
0.7355 | 311.14M | 199.30M | -230.47M | -58.89M | -1.2891 |
TAK
Takeda Pharmaceutical Co Adr
|
19.45 | 62.13B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.11 | 47.95B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.94 | 43.71B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
78.42 | 32.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
541.51 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Canopy Growth Corp Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | Canaccord Genuity | Buy |
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corp Stock (CGC) Latest News
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market - Zacks Investment Research
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
3 Huge Red Flags From Tilray's Q1 Earnings Report - The Motley Fool
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
UTMD Trades at a Premium to the Industry: How to Play the Stock? - Zacks Investment Research
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today - Zacks Investment Research
Total common shares outstanding of Canopy Growth Corporation – HAN:11L - TradingView
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors - Zacks Investment Research
VFF Stock Up 49% in Three Months: Is the Rally Sustainable? - Zacks Investment Research
Canopy Growth Corporation extends proxy deadline for share consolidation vote - Mugglehead Investment Magazine
Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock? - The Motley Fool
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know - Zacks Investment Research
Canopy Growth Corporation - Baystreet.ca
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting - Business Wire
Canopy Growth: Business Profile and TSX Market Context - Kalkine Media
Canopy Growth Corporation Share PriceWEED, RNS News, Articles, Quotes, & Charts (TSE:WEED: ) - Proactive financial news
Week in Weed – September 12, 2026 - StratCann
Cannabis - Proactive financial news
What is moving Canopy Growth (NASDAQ:CGC) shares in today's market? - Kalkine Media
Canopy Growth (TSX:WEED) Fuels New Interest Across Cannabis Markets Midcap Stocks - Kalkine Media
Canopy Growth (NASDAQ:CGC): What's Driving Amid A Cautious Session? - Kalkine Media
What Is Driving Interest in Canopy Growth (NASDAQ:CGC)? - Kalkine Media
Canopy Growth broadens Australian medical cannabis portfolio with new formats and formulations - MMJDaily
Why Is the Market Watching Canopy Growth? (NASDAQ:CGC) - Kalkine Media
What's Driving Canopy Growth Corporation (TSX:WEED) Right Now? - Kalkine Media
Can Canopy Growth (NASDAQ:CGC) Turn Revenue Growth Into a Real Turnaround? - Kalkine Media
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats, Formulations - cannabisbusinesstimes.com
CGC Looks 39.2% Overvalued on GF Value™ - GuruFocus
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations - Yahoo Finance
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. - Yahoo Finance
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. - The Motley Fool
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Canopy Growth (NASDAQ:CGC): Is Cannabis Sentiment Turning Again? - Kalkine Media
Arbutus Biopharma Corp (ABUS) Peer Comparison – Compare with Others - Value Research
Why Is Canopy Growth (NASDAQ:CGC) Narrowing Annual Losses as Stockholders Prepare to Vote on Share Consolidation? - kalkinemedia.com
Why Cannabis Stocks Like Canopy Growth (TSX:WEED) Matter Now - kalkinemedia.com
Canopy Growth (NASDAQ:CGC) Builds A New Case for Cannabis Growth - Kalkine Media
Canopy Growth Company Profile & Introduction - Moomoo
Canopy Growth (NASDAQ:CGC) Narrows Loss As Europe Drives Growth - Kalkine Media
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? - finance.yahoo.com
Is Canopy Growth (NASDAQ:CGC) Turning the Corner on Margins? - kalkinemedia.com
Canopy Growth (NASDAQ:CGC) Revenue Turns Higher After Fiscal Reset - kalkinemedia.com
Top Cannabis Stocks Worth WatchingSeptember 1st - MarketBeat
What Is Driving Canopy Growth Stock? (NASDAQ:CGC) - Kalkine Media
Is Canopy Growth (NASDAQ:CGC) Turning a Corner as Vaporizer Sales and European Shipments Climb? - kalkinemedia.com
Can Canopy Growth (TSX:WEED) Regain Canada Market Attention? - kalkinemedia.com
Canopy Growth (NASDAQ:CGC) Could Benefit From A Cannabis Policy Shift - kalkinemedia.com
Canopy Growth (TSX:WEED) Faces Changing Cannabis Market Dynamics - kalkinemedia.com
Canopy Growth Corp Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Canopy Growth Corp Stock (CGC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BAYERN JOSEPH | Director |
Sep 28 '26 |
Sale |
0.93 |
3,096 |
2,869 |
142,031 |
| Lazzarato David Angelo | Director |
Sep 28 '26 |
Sale |
0.93 |
22,380 |
20,742 |
189,479 |
| ATKINS M SHAN | Director |
Sep 28 '26 |
Sale |
0.93 |
3,096 |
2,869 |
143,421 |
| Stewart Thomas Carlton | See Remarks |
Sep 17 '26 |
Sale |
0.93 |
25,755 |
23,952 |
588,412 |
| Stewart Thomas Carlton | See Remarks |
Aug 24 '26 |
Sale |
1.47 |
2,231 |
3,280 |
614,167 |
| Gedeon Christelle | See Remarks |
Aug 24 '26 |
Sale |
1.47 |
13,344 |
19,616 |
692,162 |
| ATKINS M SHAN | Director |
Jun 26 '26 |
Sale |
0.92 |
3,197 |
2,953 |
146,517 |
| Yanofsky Theresa | Director |
Jun 26 '26 |
Sale |
0.92 |
15,054 |
13,905 |
146,415 |
| BAYERN JOSEPH | Director |
Jun 26 '26 |
Sale |
0.92 |
3,197 |
2,953 |
145,127 |
| Lazzarato David Angelo | Director |
Jun 26 '26 |
Sale |
0.92 |
22,674 |
20,944 |
211,859 |
2.17%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):